Semaglutide, marketed under the brand name Wegovy, is a weight loss service that has been approved by the FDA for use in adults with obesity or those who are overweight and have at least one weight-related health condition. Semaglutide is a once-weekly injectable medication that works by mimicking the effects of a hormone called glucagon-like peptide-1 (GLP-1) that regulates appetite and blood sugar levels. This helps to reduce cravings and promote feelings of fullness, which can lead to a reduction in calorie intake and weight loss.
Studies have shown that Semaglutide can result in significant weight loss when used in combination with a reduced-calorie diet and increased physical activity. In one study, participants who received Semaglutide lost an average of 15% of their body weight over the course of 68 weeks. Semaglutide has also been shown to have positive effects on blood pressure, cholesterol levels, and other health markers in addition to promoting weight loss. If you’re struggling to lose weight and have a BMI of 27 or greater, or have a BMI of 25 or greater and have at least one weight-related health condition, Semaglutide (Wegovy) may be a viable weight loss solution for you.